Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Early trials show an average of 24% weight loss over 48 weeks higher than semaglutide or tirzepatide
PT-141 (Bremelanotide) Selective MC4R Activation PT-141 was engineered to focus on melanocortin-4 receptors, located in the brains hypothalamus
After analyzing five years of medical records from nearly 147,000 adults with type 2 diabetes and obesity, the study authors concluded that GLP-1 use was associated with a significantly increased risk of osteoporosis, osteomalacia, and gout
Since many clinics have weight cutoffs before they will even treat a patient, some patients might pursue GLP-1s to meet the requirements, Merhi adds
Quality-controlled production
US$ 28.91
US$ 23.48
US$ 20.86
US$ 24.38
US$ 23.07
US$ 28.01
US$ 20.01
